Versant Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.7K Hold
405
﹤0.01% 1496
2026
Q1
$15.5K Buy
+405
New +$12.8K ﹤0.01% 1946
2025
Q4
Sell
-362
Closed -$7.77K 2650
2025
Q3
$7.77K Buy
362
+340
+1,545% +$7.62K ﹤0.01% 2036
2025
Q2
$564 Sell
22
-20
-48% -$585 ﹤0.01% 2541
2025
Q1
$1.54K Buy
42
+40
+2,000% +$1.38K ﹤0.01% 2309
2024
Q4
$61 Buy
+2
New +$66 ﹤0.01% 2362
2023
Q3
Sell
-16
Closed -$507 1945
2023
Q2
$507 Buy
+16
New +$517 ﹤0.01% 1831
2019
Q3
Sell
-5
Closed 1364
2019
Q2
$0 Buy
+5
New +$211 ﹤0.01% 1398

Other funds holding ATEX

Versant Capital Management's ATEX Position: Q2 2026 in Review

Versant Capital Management held its Anterix (ATEX) position steady in Q2 2026 at 405 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Versant Capital Management first reported a position in ATEX in Q2 2019 and has held it in 8 quarters since. 11 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Versant Capital Management held 405 shares of Anterix worth $41.7K as of Q2 2026.
  • Versant Capital Management left its Anterix share count unchanged in Q2 2026.
  • Anterix made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1496 holding.
  • Versant Capital Management first reported a position in Anterix in Q2 2019 and has held it in 8 quarters since.
  • 11 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.